肝细胞癌监测的患者偏好:多中心联合分析
该研究在美国7个中心对649例接受肝细胞癌监测的肝硬化或慢性乙肝患者进行选择实验联合分析,评估患者对监测检查的偏好。结果显示患者最重视监测获益(42.9%),其次为经济负担(19.4%);不同种族、民族和社会经济状况亚组的偏好存在显著差异。
要点
- 肝硬化或慢性乙肝患者接受肝细胞癌监测时最看重监测获益,其次为经济负担。
- 黑人、西班牙裔及低社会经济状况患者更重视经济负担,对监测获益重视较低。
- 通过共同决策减少经济与流程障碍或可提高监测依从性。
核心结论
- 接受肝细胞癌监测的患者优先考虑监测检查的敏感度,但偏好因种族、民族和社会经济状况而异。
- 减少经济与流程障碍并通过共同决策或可改善监测参与,尤其当不同监测方式效果相似时。
研究设计与样本
- 选择实验联合分析(choice-based conjoint survey),纳入2022至2024年美国7个中心649例接受肝细胞癌监测的肝硬化或慢性乙肝患者。
- 参与者面对15个情景,基于检查属性在监测方式间进行选择。
主要发现
- 队列中位年龄60岁,51%男性,60%白人,10%黑人,20%西班牙裔;12%有Medicaid保险,38%有Medicare保险。
- 监测获益是最受重视的属性(42.9%;95%CI 40.6%-45.1%),其次为经济负担(19.4%;95%CI 18.1%-20.7%)。
- 对检查流程(12.3%;95%CI 11.5%-13.2%)、检查地点(9.2%;95%CI 8.5%-10.0%)、检查时长(8.3%;95%CI 7.8%-8.7%)和身体伤害(7.9%;95%CI 7.2%-8.6%)的重视程度较低。
- 与白人相比,黑人参与者对监测获益重视显著更低,对经济负担(P<0.001)和检查时长(P=0.001)重视更高。
- 西班牙裔比非西班牙裔更重视经济负担(P<0.001);教育程度低于高中(P=0.01)、有Medicaid保险(P=0.001)、收入低于25000美元(P<0.001)者更重视经济负担而较少重视监测获益。
临床怎么用
- 临床决策时应考虑患者对监测获益和经济负担的不同重视程度,针对黑人、西班牙裔及低社会经济状况患者优化沟通。
- 通过共同决策减少经济与流程障碍,可能提高肝细胞癌监测的参与度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Several emerging modalities are available for hepatocellular carcinoma (HCC) surveillance; however, patient preferences for surveillance tests-particularly across key subgroups such as race/ethnicity, income, and education level-are poorly characterized. METHODS: We conducted a choice-based conjoint survey among patients with cirrhosis and chronic hepatitis B undergoing HCC surveillance (from 2022 to 2024) at 7 centers in the United States. Participants were presented with 15 scenarios, where they chose between surveillance modalities based on test attributes. RESULTS: We included 649 patients, with a median age of 60 years, 51% male, 60% White, 10% Black, and 20% Hispanic. The cohort reflected substantial socioeconomic variation including 12% with Medicaid and 38% with Medicare. The highest priority attribute was surveillance benefits (42.9%; 95% confidence interval [CI] 40.6%-45.1%), followed by financial harms (19.4%; 95% CI 18.1%-20.7%). Patients placed less priority on test logistics (12.3%; 95% CI 11.5%-13.2%), test location (9.2%; 95% CI 8.5%-10.0%), test duration (8.3%; 95% CI 7.8%-8.7%), and physical harms (7.9%; 95% CI 7.2%-8.6%). In subgroup analyses, Black participants placed significantly lower importance on surveillance benefits and higher importance on financial harms ( P < 0.001) and test duration ( P = 0.001) compared with White participants. Hispanic participants also prioritized financial harms more than non-Hispanic participants ( P < 0.001), a pattern consistent with cost-related concerns seen across other lower socioeconomic status (SES) subgroups. Lower SES individuals with below a high school education ( P = 0.01), Medicaid insurance ( P = 0.001), and income below $25,000 ( P < 0.001) assigned greater importance to financial harms and less to surveillance benefits. DISCUSSION: Patients with undergoing HCC surveillance prioritize surveillance test sensitivity; however, results vary by race, ethnicity, and SES. Improving access by reducing financial and logistical barriers through shared decision-making may enhance surveillance, particularly when modalities present with similar effectiveness.
引用
- Kao KD, Troost JP, Yang JD, et al. Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multisite Conjoint Analysis. Am J Gastroenterol. 2026. PMID: 41979434. doi:10.14309/ajg.0000000000004023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。